InvestSMART

EBR Systems Inc (ASX:EBR)

ALERT: Price-sensitive ASX Announcement for EBR
Current share price for EBR : $0.290 0.015 (5.45%)+
Announcement
Release
30 Jul 2026 9:46AM
Price at Release
$0.275
Full Release
download
Summary
EBR Systems Inc reported progress in the Q2 2026 commercial rollout of its WiSE technology, the only wireless cardiac pacing device for heart failure. During this period, 46 WiSE commercial implants were completed, with a total of 117 implants across the pilot phase and Limited Market Release. The company signed 17 new purchasing contracts and trained 26 new physicians. The focus is shifting to deeper utilisation within activated accounts rather than expanding new sites. EBR Systems expects Q2 2026 revenue to be between $2.50M to $2.60M, based on preliminary results. The company completed a partial A$150 million capital raise to support its scale-up efforts and received a CMS National Coverage Determination initiation, indicating potential for broader Medicare coverage. EBR actively engaged with investors and media to promote understanding of its commercial strategy.
Key Points
  • 46 WiSE commercial implants completed in Q2 2026.
  • Total implants across phases reached 117.
  • 17 new purchasing contracts signed.
  • 26 new physicians trained.
  • Revenue expectations between $2.50M and $2.60M for Q2 2026.
  • A$150 million capital raise partly completed.
  • CMS initiated National Coverage Determination process for WiSE.
  • Focus on deeper utilization within existing accounts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.